Baader Bank set a CHF 256 price objective on Roche Holding Ltd. (VTX:ROG) in a report released on Tuesday morning. The brokerage currently has a buy rating on the healthcare company’s stock.

Other equities research analysts also recently issued reports about the stock. HSBC Holdings PLC set a CHF 205 price objective on shares of Roche Holding and gave the company a sell rating in a report on Tuesday. Morgan Stanley set a CHF 260 price objective on shares of Roche Holding and gave the company a neutral rating in a report on Wednesday, July 26th. Credit Suisse Group set a CHF 260 price objective on shares of Roche Holding and gave the company a neutral rating in a report on Monday, October 16th. Berenberg Bank set a CHF 260 price objective on shares of Roche Holding and gave the company a neutral rating in a report on Monday. Finally, Deutsche Bank AG set a CHF 254 price objective on shares of Roche Holding and gave the company a neutral rating in a report on Friday, November 17th. Three research analysts have rated the stock with a sell rating, eight have given a hold rating and seven have given a buy rating to the company’s stock. The stock presently has an average rating of Hold and an average price target of CHF 261.78.

Shares of Roche Holding (VTX ROG) opened at CHF 246 on Tuesday. Roche Holding has a fifty-two week low of CHF 218.30 and a fifty-two week high of CHF 273.

ILLEGAL ACTIVITY NOTICE: This news story was originally posted by Watch List News and is the property of of Watch List News. If you are viewing this news story on another publication, it was stolen and republished in violation of United States and international copyright laws. The correct version of this news story can be viewed at https://www.watchlistnews.com/roche-holding-ltd-rog-given-a-chf-256-price-target-at-baader-bank/1719116.html.

Roche Holding Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company’s operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics.

Analyst Recommendations for Roche Holding (VTX:ROG)

Receive News & Ratings for Roche Holding Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche Holding Ltd. and related companies with Analyst Ratings Network's FREE daily email newsletter.